Disclaimer: Early release articles are not considered as final versions. Any changes will be reflected in the online version in the month the article is officially released.
Volume 31, Number 4—April 2025
Synopsis
Maternal and Fetal Implications of Oropouche Fever, Espírito Santo State, Brazil, 2024
João Paulo Cola1, Ana Paula Brioschi dos Santos1, Raphael Lubiana Zanotti, Adriana Endlich da Silva Dela Costa, Karina Bertazo Del Carro, Lesliane de Amorim Lacerda Coelho, Angelica Espinosa Miranda2, and Creuza Rachel Vicente2
Table 3
Pregnancy and neonatal outcomes in 14 pregnant women with Oropouche virus infection and concluded pregnancy, Espírito Santo State, Brazil, March 28–December 22, 2024*
| Characteristic | No. (%) |
|---|---|
| Type of birth | |
| Cesarean | 10 (71.43) |
| Vaginal |
4 (28.57) |
| Gestational age at birth | |
| Term, 37–41 wks |
14 (100.0) |
| Birthweight and length | |
| Adequate | 14 (100.00) |
| Apgar score >7 |
14 (100.00) |
| Positive RT-PCR for Oropouche virus RNA | |
| Placenta | 5 (38.46) |
| Neonate | 2 (15.38) |
*Excludes 1 case (1.37%) of spontaneous abortion. No cases were preterm (<37 weeks), had low birthweight and length, had an Apgar score of 0–6, or had detectable Oropouche virus RNA in umbilical cord fluid. RT-PCR, reverse transcription PCR.
1These first authors contributed equally to this article.
2These senior authors contributed equally to this article.
Page created: February 05, 2025
Page updated: February 24, 2025
Page reviewed: February 24, 2025
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.